Soluble urokinase-type plasminogen activator receptor in sickle cell disease-associated chronic kidney disease

被引:4
作者
Afangbedji, Nowah [1 ,2 ]
Kumari, Namita [1 ]
Diaz, Sharmin [1 ]
Wen, Fayuan [1 ]
Taylor, James G. [1 ,3 ]
Nekhai, Sergei [1 ,3 ,4 ]
Jerebtsova, Marina [4 ,5 ]
机构
[1] Howard Univ, Ctr Sickle Cell, Washington, DC USA
[2] Howard Univ, Dept Physiol & Biophys, Washington, DC USA
[3] Howard Univ, Dept Med, Washington, DC USA
[4] Howard Univ, Coll Med, Dept Microbiol, Washington, DC USA
[5] Howard Univ, Coll Med, Dept Microbiol, Room 311,520 St NW, Washington, DC 20059 USA
基金
美国国家卫生研究院;
关键词
UPAR;
D O I
10.1182/bloodadvances.2022008374
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1854 / 1857
页数:4
相关论文
共 50 条
  • [21] Expression of urokinase-type plasminogen activator receptor is correlated with metastases of lingual squamous cell carcinoma
    Wang, Jing
    Guo, Fuping
    Wei, Hongyu
    Dong, Jijun
    Wu, Junzheng
    BRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY, 2006, 44 (06) : 515 - 519
  • [22] A novel role for the urokinase-type plasminogen activator receptor in apoptosis of malignant gliomas
    Kin, Y
    Chintala, SK
    Go, Y
    Sawaya, R
    Mohanam, S
    Kyritsis, AP
    Rao, JS
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2000, 17 (01) : 61 - 65
  • [23] Plasma Soluble Urokinase-Type Plasminogen Activator Receptor Level as a Predictor of the Severity of Community-Acquired Pneumonia
    Tsai, Ping-Kun
    Tsao, Shih-Ming
    Yang, Wei-En
    Yeh, Chao-Bin
    Wang, Hsiang-Ling
    Yang, Shun-Fa
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2019, 16 (06)
  • [24] The diagnostic value of serum urokinase-type plasminogen activator receptor in acute appendicitis
    Aygun, Ali
    Gunaydin, Mucahit
    Ozozan, Omer Vefik
    Cihan, Murat
    Karakahya, Murat
    ULUSAL TRAVMA VE ACIL CERRAHI DERGISI-TURKISH JOURNAL OF TRAUMA & EMERGENCY SURGERY, 2019, 25 (05): : 467 - 473
  • [25] Circulating soluble urokinase plasminogen activator receptor levels and peripheral arterial disease outcomes
    Tahhan, Ayman Samman
    Hayek, Salim S.
    Sandesara, Pratik
    Hajjari, Jamal
    Hammadah, Muhammad
    O'Neal, Wesley T.
    Kelli, Heval M.
    Alkhoder, Ayman
    Ghasemzadeh, Nima
    Ko, Yi-An
    Aida, Hiroshi
    Gafeer, Mohamad Mazen
    Abdelhadi, Naser
    Mohammed, Kareem Hosny
    Patel, Keyur
    Arya, Shipra
    Reiser, Jochen
    Vaccarino, Viola
    Sperling, Laurence
    Quyyumi, Arshed
    ATHEROSCLEROSIS, 2017, 264 : 108 - 114
  • [26] Urokinase plasminogen activator receptor levels in Behcet's disease
    Birengel, Serhat
    Yalcindag, F. Nilufer
    Yalcindag, Ali
    Sahli, Esra
    Batioglu, Figen
    THROMBOSIS RESEARCH, 2011, 128 (03) : 274 - 276
  • [27] Expression and localization of urokinase-type plasminogen activator receptor in bovine cumulus-oocyte complexes
    Garcia, Daniela C.
    Miceli, Dora C.
    Rizo, Gabriela
    Garcia, Elina V.
    Valdecantos, Pablo A.
    Roldan-Olarte, Mariela
    ZYGOTE, 2016, 24 (02) : 230 - 235
  • [28] Clinical relevance of urokinase-type plasminogen activator, its receptor and inhibitor type 1 in ovarian cancer
    Tecimer, C
    Doering, DL
    Goldsmith, LJ
    Meyer, JS
    Abdulhay, G
    Wittliff, JL
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2000, 10 (05) : 372 - 381
  • [29] Urokinase-type plasminogen activator receptor (uPAR) expression is associated with T-stage and survival in urothelial carcinoma of the bladder
    Dohn, Line Hammer
    Illemann, Martin
    Hoyer-Hansen, Gunilla
    Christensen, Ib J.
    Hostmark, Jens
    Litlekalsoy, Jorunn
    von der Maase, Hans
    Pappot, Helle
    Laerum, Ole D.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2015, 33 (04) : 165.e15 - 165.e24
  • [30] Structure-function relationships in the interaction between the urokinase-type plasminogen activator and its receptor
    Ploug, M
    CURRENT PHARMACEUTICAL DESIGN, 2003, 9 (19) : 1499 - 1528